Hematuria Treatment Market size ($1,103.61 million by 2028), led by Urinary Tract Infections (17.31% market share in 2020), Impact of the Coronavirus Outbreak and Global Analysis and Forecast by TheInsightPartners.com (2023)

New York, Oct. 29, 2021 (GLOBE NEWSWIRE) --Hematuria Treatment Market: Important Information
According to our new research study, tooHematuria Treatment MarketSize and Prognosis to 2028 - Impact of COVID-19 and global analysis by treatment (drugs, therapies and others), indication (urinary tract infections, kidney stones, urethritis, blood cancer, bladder stones, prostate cancer, cystitis, trauma, intense exercise). ), polycystic kidney disease, endometriosis, and menstrual periods), type (macrohematuria, microscopic hematuria, idiopathic hematuria, and fluric hematuria), and end-user (hospitals, clinics, and ASCs and others), and geography.

report coveragedetails
Market Size Value in$932.89 million in 2021
Market size value per$1,103.61 million in 2028
growth rate2.4% CAGR from 2021 to 2028
forecast period2021-2028
what base2021
number of pages215
number of tables111
Number of graphics and illustrations87
Historical data availableSim
segments coveredTreatment, Indication, Type, End User and Geography
Alcance RegionalNorth America; Europe; Asia Pacific; Latin America; MEANS
country areaUSA, UK, Canada, Germany, France, Italy, Australia, Russia, China, Japan, South Korea, Saudi Arabia, Brazil, Argentina
report coverageRevenue Forecast, Company Ranking, Competitive Landscape, Growth Drivers and Trends

Get unique sample pages of Hematuria Treatment Market Size - Impact of COVID-19 and Global Analysis with Strategic Insights athttps://www.theinsightpartners.com/sample/TIPRE00004601/

Hematuria Treatment Market: Competitive Landscape and Key Developments
AstraZeneca; Bristol-Myers Squibb Company; F. HOFFMANN-LA ROCHE LTDA.; GlaxoSmithKline plc.; Janssen Pharmaceuticals; Merck & Co., Inc.; Novartis AG; Pfizer Inc.; Sun Pharmaceutical Industries Ltd.; and Boehringer Ingelheim International GmbH are among the leading companies in the hematuria treatment market. The major players are focused on expanding and diversifying their market presence and attracting a new customer base, thereby capitalizing on existing business opportunities.

In September 2021, AstraZeneca worked with VaxEquity to discover, develop and commercialize the proprietary autoamplifying RNA (saRNA) therapeutic platform developed at Imperial College London.

In September 2021, Merck announced its definitive agreement to acquire Acceleron. After purchasing the shares in the public offering, Acceleron will become a subsidiary of Merck.

Im August 2021 hat Pfizer Inc.

As of June 2021, Eisai Co., Ltd. and Bristol-Myers Squibb Company have signed an exclusive global strategic collaboration agreement for the co-development and co-commercialization of MORAb-202, an antibody-drug conjugate (ADC).

As of July 2021, GlaxoSmithKline plc. and Alector announced a strategic global collaboration for the development and commercialization of two potentially first-in-class, clinical-stage monoclonal antibodies (AL001 and AL101) designed to increase progranulin (PGRN) levels.

The United States has the largest share of the hematuria treatment market in North America. The market in this region is expected to witness steady growth in the coming years owing to factors such as increasing prevalence of Chronic Kidney Disease (CKD) and increasing number of product launches by major players. Asia Pacific Hematuria Treatment Market is expected to grow at the fastest CAGR during the forecast period. India and China are expected to be major contributors to the market in this region due to factors such as increasing prevalence of conditions such as urinary tract infections and kidney stones, increased awareness of hematuria and its treatments, and extensive research and development. Ongoing activities to promote a positive attitude towards drug development for hematuria.

Download Sample PDF Brochure of Hematuria Treatment Market Size and Growth Research Reporthttps://www.theinsightpartners.com/sample/TIPRE00004601/

Expanding Scope of Related Treatments to Offer Significant Growth Opportunities for Hematuria Treatment Market Players:
Technological advances in medical devices and diagnostic procedures have led to several options for treating indications related to hematuria, such as: B. kidney stones, bladder stones and urinary tract infections. The use of advanced treatment technologies aims to improve patient care. For example, the implementation of robotics in surgeries to treat urolithiasis has gained popularity in recent years. Today, Intuitive Surgical Inc.'s Vinci Surgical System is widely used in performing surgeries to treat urolithiasis. Likewise, the utilization of endourological procedures for kidney stones has increased significantly in several countries in North America, Europe and Asia. Advances in related indications are also expected to support the global hematuria treatment market during the forecast period. The high prevalence of hematuria-associated indications and growing awareness of treatment options and improved healthcare spending are driving the market growth. However, undiagnosed cases of associated indications hamper the effectiveness of hematuria treatments and hamper market growth. Additionally, the expanded scope of associated treatments is expected to offer significant growth opportunities for market players to expand their clientele.

Additionally, continued support from the US government offers lucrative opportunities in the country. In addition, various other factors responsible for promoting the growth of the US market are efforts by international players to penetrate the US market, advances in drug research and innovation being carried out by major players, and an increased Consciousness. among the population. The aging population, which is more likely to suffer from hematuria symptoms, is expected to propel the growth of the market. In addition, the researchers found significant differences in the prevalence of chronic kidney disease (CKD) in people across the European Union, with the lowest rates in Norway and central Italy and the highest rates in north-eastern Germany. These changes appear to be independent of the prevalence of diabetes, hypertension and obesity.

Hematuria Treatment Market: Segment Overview
On the basis of treatment, the Hematuria Treatment market is segmented into Drugs, Therapies, and Others. The Drugs & Therapies segment is expected to account for the highest market share in 2020. Additionally, it is expected to register the highest CAGR in the market over the period 2020-2028. On the basis of indication, the hematuria treatment market is segmented into urinary tract infection, kidney stones, urethritis, blood cancer, bladder stones, prostate cancer, cystitis, trauma, vigorous exercise, polycystic kidney disease, endometriosis and menstruation. The Urinary Tract Infections segment led the market with a share of 17.31% in 2020 and is expected to maintain its dominance during the forecast period. On the basis of type, the hematuria treatment market is segmented into macroscopic hematuria, microscopic hematuria, idiopathic hematuria and corridor hematuria. The microscopic hematuria segment will have the highest market share in 2021. The gross hematuria market is anticipated to grow at a CAGR of 2.6% during the forecast period. Based on end-use, the Hematuria Treatment market is further segmented into Hospitals, Clinics, ASCs, and Others. The hospital segment led the market in 2020 with a share of 36.52% and is expected to maintain its dominance during the forecast period.

The COVID-19 outbreak has significantly impacted the incidence and management of kidney diseases, including acute kidney injury (AKI), end-stage kidney disease (ESKD), glomerulonephritis (GN), and kidney transplantation. Recent studies in North America show a much higher incidence, likely due to the higher prevalence of comorbidities such as hypertension, diabetes and chronic kidney disease (CKD). A new analysis shows people with kidney failure have faced exceptionally high hospitalization and mortality rates during the COVID-19 pandemic. The findings, which will appear in an upcoming issue of the Journal of the American Society of Nephrology (JASN), support the prioritization of these patients in COVID-19 vaccination programs. Many patients who require dialysis several times a week in healthcare facilities have been unable to enter hospitals during the COVID-19 outbreak. Mexico was one of the hardest-hit countries in the world by COVID-19 infections, with one of the highest mortality rates (9.8%) among both the general population and health workers.

Request a copy of the research report on Hematuria Treatment Market Size, Share, Strategic Insights and Forecasts 2021-2028https://www.theinsightpartners.com/buy/TIPRE00004601/

MENA countries experienced three waves of the COVID-19 pandemic. A relative test frequency can be used as a surrogate indicator of diagnostic system performance. The UAE and Bahrain are regional leaders in testing, outperforming some advanced economies. COVID-19-related mortality is higher in dialysis and transplant recipients than in the general population, and underlying CKD is a risk factor leading to disease severity and mortality in patients with COVID-19. AKI is a common complication in patients with severe COVID-19. Critically ill patients in intensive care units (ICUs), especially those on mechanical ventilation, are more likely to require dialysis than patients with milder illnesses. As a result, COVID-19 has had a significant impact on the global hematuria therapy market. However, the situation is steadily improving. Primary kidney involvement is common in SARS-CoV-2 infections and is associated with a higher mortality rate. Diagnosing acute AKI, CKD, and KRT as major risk factors for mortality in patients with COVID-19 is an essential step to reduce future mortality and long-term morbidity in hospitalized patients with severe infection.

Key Questions for Hematuria Treatment Market Applications:

  • What is the treatment for hematuria?
  • What are the key factors driving the Global Hematuria Treatments Market?
  • What is the CAGR of the Hematuria Treatments Market during the forecast period?
  • What Type of Treatment Led the Hematuria Treatment Market?
  • Which indication had the highest share of the hematuria treatment market?
  • Which type had the largest share of the hematuria treatment market?
  • Which end-user had the largest share of the Hematuria Treatment Market?
  • Who are the key manufacturers in Hematuria Treatments market space?
  • What are the top companies having market share in the Hematuria Treatments Market?
  • In which region is significant market demand for hematuria treatment is anticipated in the coming years?
  • What impact will COVID 19 have on the hematuria treatment market in the coming years?

About Us:
Insight Partners is a comprehensive industry research provider of actionable intelligence. We help our clients find solutions to their research needs through our consulting services and syndicated research. We specialize in industries such as Semiconductor & Electronics, Aerospace & Defense, Automotive & Transportation, Biotechnology, Health IT, Manufacturing & Construction, Medical Devices, Technology, Media & Telecom, Chemicals & Materials.

Contact us:
If you have any questions about this report or would like more information, please contact us:

Contact Person: Sameer Joshi
E-Mail: sales@theinsightpartners.com
Phone: +1-646-491-9876
press release -https://www.theinsightpartners.com/pr/hematuria-tratamiento-mercado

Connect with us at:
RSS Sources:https://www.theinsightpartners.com/feed/|https://www.openpr.com/news/archive/139407/The-Insight-Partners.html

Hematuria Treatment Market size ($1,103.61 million by 2028), led by Urinary Tract Infections (17.31% market share in 2020), Impact of the Coronavirus Outbreak and Global Analysis and Forecast by TheInsightPartners.com (1)


What is the market for urinary tract infection treatment? ›

The urinary tract infection therapeutics market was valued at USD 8660.37 million in 2021 and is expected to register a CAGR of 3.5% during the forecast period 2022-2027.

Is idiopathic hematuria common? ›

Hematuria is common and can have many different causes. These causes include: Inflammation: kidney, urethra, bladder, or prostate (in men) Abnormal structures in the urinary tract: Kidneys that contain cysts (fluid-filled sacs) or are blocked may lead to any type of hematuria.

What's the strongest antibiotic for UTI? ›

Ciprofloxacin (Cipro) or levofloxacin (Levaquin)

Healthcare providers usually save these antibiotics for more complicated or severe types of UTIs.

What is best antibiotic for urinary tract infection? ›

Medicines commonly used for simple UTI s include:
  • Trimethoprim and sulfamethoxazole (Bactrim, Bactrim DS)
  • Fosfomycin (Monurol)
  • Nitrofurantoin (Macrodantin, Macrobid, Furadantin)
  • Cephalexin.
  • Ceftriaxone.
Sep 14, 2022

Can hematuria damage kidneys? ›

Hematuria arising from injury in the glomerular filtration barrier, results in passage of red blood cells into the urinary space; promoting oxidative stress, inflammation, and structural damage to the kidney [2,3,4,5,6,7,8].

What virus can cause hematuria? ›

Hematuria and renal injury have been commonly described in viral respiratory infections including influenza A and B, adenovirus and other pathogens.

What cancers cause hematuria? ›

In most cases, blood in the urine (called hematuria) is the first sign of bladder cancer. There may be enough blood to change the color of the urine to orange, pink, or, less often, dark red.

Why won't my UTI clear up with antibiotics? ›

There are three primary reasons that this may happen: an antibiotic-resistant strain of bacteria is causing your UTI. another type of bacteria, fungi, or virus may be causing your infection. your UTI may be another condition that has UTI-like symptoms.

Is banana good for urinary tract infection? ›

Bananas and other high-fiber foods can be good for urinary tract health and preventing urinary tract infections (UTIs) by encouraging regular bowel movements and relieving pressure on urine flow.

Can I get rid of UTI without antibiotics? ›

Many times a UTI will go away on its own. In fact, in several studies of women with UTI symptoms, 25% to 50% got better within a week — without antibiotics.

What is the fastest way to cure a urine infection? ›

If you have a UTI, make an appointment with a healthcare provider as soon as possible. The fastest way to feel better is by taking an antibiotic to kill the bacteria causing your infection.

How much water does it take to flush out a UTI? ›

During the infection — and after — make sure to drink a lot of water, at least 12 8-ounce cups per day. This will flush out your system and help prevent future infections. If you feel like you've got to go, GO! Don't hold it, as this simply delays getting rid of more bacteria.

How do you get rid of a UTI fast at home? ›

Ways to relieve UTI discomfort at home
  1. Try heat. Apply warm compresses, a hot water bottle or heating pad to your pelvis. ...
  2. Boost your water intake. Drinking six to eight, 8-oz. ...
  3. Take an OTC medication. ...
  4. Put on your comfy clothes. ...
  5. Sip some cranberry juice. ...
  6. Steer clear of bladder irritants.
Apr 6, 2022

What happens if you dont treat hematuria? ›

Ignoring hematuria can lead to the worsening of serious conditions like cancer and kidney disease, so you should talk to your doctor as soon as possible. Your doctor can analyze your urine and order imaging tests to determine the cause of the hematuria and create a plan for treatment.

Can you live with hematuria? ›

If you notice blood in your urine, don't panic, but do take it seriously. In many cases, blood in the urine, otherwise known as hematuria, can be easily treated. However, it can also point to a serious problem, such as cancer. Patients usually have a lot of questions when they first see blood in their urine.

What is the most common reason for hematuria? ›

Urinary Tract Infections (UTIs)

A bacterial infection in one or more components of the urinary tract is among the most frequently seen causes of hematuria. The urinary tract includes the urethra, ureters, bladder, and kidneys.

What organ causes hematuria? ›

This condition happens when the kidneys or other parts of the urinary tract let blood cells leak into urine. Different problems can cause this leaking to happen, including: Urinary tract infections (UTIs).

What deficiency causes hematuria? ›

Vitamin D deficiency and hematuria are both common health problem in general population. The association between vitamin D deficiency and hematuria was noticed in this study, particularly in postmenopausal women. Patients with vitamin D deficiency should be concern about the risk of hematuria and related disease.

What parasite causes hematuria? ›

Without treatment, schistosomiasis can persist for years. Signs and symptoms of chronic schistosomiasis include: abdominal pain, enlarged liver, blood in the stool or blood in the urine, and problems passing urine.

What is the most common cause of gross hematuria in a patient older than 50 years of age? ›

BPH is the most common cause of hematuria in men over age 50. Prostate infection (prostatitis) Tumors in the bladder, kidney or prostate. Vigorous exercise and trauma.

How often is a malignancy found in a patient with gross hematuria? ›

The incidence of bladder cancer in a patient with gross hematuria is 20 percent14,15 and with microscopic hematuria is 2 percent. Symptoms of bladder irritation, such as urinary frequency and urgency, more commonly occur in patients with bladder carcinoma in situ.

Can stress cause blood in urine? ›

Stress cannot cause blood in urine, but the conditions that can are worth getting checked out by a doctor. If you or a loved one is experiencing hematuria, seek help as soon as possible from a trusted medical team near you.

What is the market size for UTI? ›

The global urinary tract infection testing market size was estimated at USD 553.91 million in 2021 and is expected to expand at a compound annual growth rate (CAGR) of 4.1% from 2022 to 2030.

What 3 antibiotics are considered first-line therapy for UTIs? ›

First-line antimicrobial options — The preferred agents for empiric therapy of acute simple cystitis are nitrofurantoin monohydrate/macrocrystals, trimethoprim-sulfamethoxazole, fosfomycin, and, if available, pivmecillinam because of the favorable balance between efficacy and adverse effects (including the risk of ...

Do they sell over the counter meds for a UTI? ›

Antibiotics are the only medication that can cure a UTI. Antibiotics are not available over the counter.

Can you buy UTI treatment over the counter? ›

Remember: There's no over-the-counter cure for a UTI. Only your doctor can prescribe a UTI antibiotic to rid the bacteria causing the infection.

Do you pee large amounts with UTI? ›

Infections of the bladder (cystitis) or urethra (tube that carries urine out of the body) are known as lower UTIs. These can cause: a need to pee more often than usual.

What is normal range of UTI? ›

pH – 4.5-8. Specific gravity – 1.005-1.025. Glucose - ≤130 mg/d. Ketones – None.

How critical is a UTI? ›

If you don't treat a UTI, a long-lasting kidney infection can hurt your kidneys forever. It can affect the way your kidneys function and lead to kidney scars, high blood pressure, and other issues. Sometimes it can even be life-threatening.

Can azo get rid of UTI? ›

No, AZO Urinary Tract Defense does not cure a urinary tract infection. Its purpose is to keep you comfortable and to control the infection until you can see your primary care provider. Your doctor will prescribe an antibiotic medication capable of eliminating the bacteria responsible for the infection.

What is the quickest antibiotic for UTI? ›

Which antibiotic gets rid of a UTI fastest?
  • Sulfamethoxazole/trimethoprim is a first-choice medication and can treat a UTI in as little as 3 days. ...
  • Nitrofurantoin is another first-choice option for UTIs, but you typically have to take it for a week to be sure you are all better.
Oct 24, 2022

How long does it take for a UTI to go away without antibiotics? ›

How long does a UTI last untreated? Some UTIs will go away on their own in as little as 1 week. However, UTIs that do not go away on their own will only get worse over time. If you think you have a UTI, speak with a doctor about the best course of action.

What foods prevent UTI? ›

Foods High in Vitamin C

What we commonly call Vitamin C is also known as ascorbic acid, which can reduce the acidity level in urine, helping to prevent UTIs. Many foods contain Vitamin C, including oranges, grapefruits, tomatoes, broccoli, red berries, spinach and cauliflower to name just a few.

What are bladder irritating foods? ›

Bladder irritants
  • Coffee, tea and carbonated drinks, even without caffeine.
  • Alcohol.
  • Certain acidic fruits — oranges, grapefruits, lemons and limes — and fruit juices.
  • Spicy foods.
  • Tomato-based products.
  • Carbonated drinks.
  • Chocolate.

What happens if UTI won't go away with antibiotics? ›

If you have a UTI that isn't responding to antibiotic treatment, further testing will likely begin with a urine culture to analyze the bacteria causing the infection. If another type of bacteria, fungi, or virus is responsible for your UTI, your doctor will prescribe a more appropriate treatment.

What is the powder drink for UTI? ›

Fosfomycin (Monurol) is an antibiotic used for treating urinary tract infections (UTIs) in women. It is available as a powder medication that you mix with water before using it.

How do you sleep with a UTI? ›

Of course, make sure your bladder is completely empty before going to bed. You might also consider setting alarms during the night so that you can wake up and use the bathroom. Tools like a hot water bottle, heating pad, or even over-the-counter pain relievers can all help you with nighttime discomfort, too.

Why does UTI keep coming back? ›

Having a suppressed immune system or chronic health condition can make you more prone to recurring infections, including UTIs. Diabetes increases your risk for a UTI, as does having certain autoimmune diseases, neurological diseases and kidney or bladder stones.

Top Articles
Latest Posts
Article information

Author: Patricia Veum II

Last Updated: 03/02/2023

Views: 5817

Rating: 4.3 / 5 (44 voted)

Reviews: 83% of readers found this page helpful

Author information

Name: Patricia Veum II

Birthday: 1994-12-16

Address: 2064 Little Summit, Goldieton, MS 97651-0862

Phone: +6873952696715

Job: Principal Officer

Hobby: Rafting, Cabaret, Candle making, Jigsaw puzzles, Inline skating, Magic, Graffiti

Introduction: My name is Patricia Veum II, I am a vast, combative, smiling, famous, inexpensive, zealous, sparkling person who loves writing and wants to share my knowledge and understanding with you.